Johnson & Johnson is ordered to pay $572 million for its role in Oklahoma's opioid epidemic; President Trump eliminates protection of sick immigrants to remain in the United States; a federal judge is expected to rule on the Missouri law banning abortion after 8 weeks today.
Johnson & Johnson has been ordered by an Oklahoma judge to pay $572 million in restitution for their role in the state’s opioid crisis, according to Kaiser Health News. Oklahoma had originally sued for $17 billion as they attributed responsibility to the drugmaker for deceptive marketing practices that resulted in the deaths of 6000 citizens. Judge Thad Balkman cited that “the opioid crisis is an imminent danger and menace to Oklahomans,” in delivering his decision Monday. Johnson & Johnson released a statement announcing their plans to appeal the decision.
The Trump administration issued letters to families this month announcing their elimination of a protection for immigrants to remain in the country and avoid deportation while they or their relatives receive life-saving medical treatments. The Associated Press reports that the policy change became effective on August 7 and affects all pending requests, including from immigrants seeking a renewal of their 2-year authorization and first-time applicants. This move adds to the aggressive stance Trump has taken on immigrants as the administration wants to deny green cards to immigrants who use Medicaid, food stamps, and other types of public assistance.
A federal judge announced he will rule today on whether Missouri’s new abortion law banning abortions at or after 8 weeks of pregnancy will go into scheduled effect this week, reported by The Associated Press. US District Judge Howard Sachs will issue his decision after hearing arguments by Planned Parenthood and the American Civil Liberties Union on Monday. The law, which would additionally ban abortions based solely on race, sex, or a diagnosis, is scheduled to become effective Wednesday barring Sachs’ ruling.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen